CELL SEPARATION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Top Strategies Followed by Global Cell Separation Market Players

• Established Players: Leading companies in the global cell separation market heavily invest in research and development to innovate advanced products. Leading companies prioritize extensive research and development to innovate high-performance products.
  • For instance, AstraZeneca announced a US$ 3.5 billion investment in the United States by the end of 2026, focusing on expanding research and manufacturing capabilities, which includes advancements in biotechnology sectors
• Mid-Level Players: Companies strive to deliver affordable, high-quality products to attract a wider customer base. Miltenyi Biotec provides kits and reagents for manual cell separation at competitive prices. Stemcell Technologies develops kits and systems optimized for scale and budgets. Beckman Coulter focuses on usability and value with instruments like the CytoFLEX flow cytometer and reagents.
• Small-Scale Players: Small players leverage niche expertise. Precision for Medicine specializes in veterinary cell separation. Anthropic focuses on AI-based cell separation tools. Microfluidic Chipshop develops organ-on-chip microfluidic devices for cell research.

Emerging Startups - Cell Separation Industry Ecosystem

• Innovative Technologies: Companies like Celularity are developing AI platforms for automated, large-scale isolation of stem cells from placental tissue. CytoReason applies AI to accelerate the discovery of novel cell markers. Resolution Biosciences is commercializing acoustic-based cell sorting platforms for single-cell multi-omics. These technologies could disrupt current solutions and transform cell-based research.
• Sustainable Solutions: Bolt Threads creates biodegradable materials like microbial cellulose as an alternative to plastic consumables in cell processing. Circular economy startups like Solugen and Anthropic upcycle industrial waste to produce reagents and media for cell culture, contributing to sustainability goals. Their solutions could boost the adoption of greener technologies.
• Market Contribution: Partnerships with established companies or research institutions are common among startups to drive technological and sustainable innovation. For instance, Ring Therapeutics engaged a global ecosystem of R&D experts to expand the potential of its Anellogy platform, aiming to accelerate the clinical translation of its therapeutics.

Key Developments:

• In November 2024, Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, expanded its product portfolio with a new human B cell isolation kit and updated protocols for existing isolation kits. Unveiled at the 105th American Association of Immunologists annual meeting, the new products leverage Akadeum’s microbubble-based Buoyancy-Activated Cell Sorting (BACS) technology, which eliminates the need for columns or magnets, offering higher yields, faster processing, and simpler workflows.
• In April 2024, GenScript, a life sciences company, and Multiply Labs, a company in robotics, announced a strategic partnership to automate the cell isolation phase of cell therapy manufacturing. This collaboration aims to streamline the labor-intensive process of isolating cells using immunomagnetic beads, which currently involves manual handling of complex closed-system consumables, ensuring greater efficiency and precision.
• In November 2023, LevitasBio, a life sciences company, partnered with Planet Innovation, a healthtech innovation and manufacturing company, to develop LeviCell EOS system, an advanced cell isolation and enrichment platform launched mid-year with strong early adoption in top U.S. research labs. Building on Levitation Technology from LeviCell 1.0, the EOS enriches cell populations without stress or damage, delivering higher-quality samples for research in cell and gene therapy, pharmaceuticals, and more.
• In January 2022, Sony Corporation, a Japan-based manufacturer of consumer electronics products, unveiled CGX10, a high-speed, high-purity Cell Isolation System designed for closed-system operation. This ensures sterile cell sorting and analysis, crucial for fields like cell-based immunotherapy, which is increasingly used to treat cancer and autoimmune disorders.

• Thermo Fisher Scientific, Inc.
• Becton, Dickinson and Company
• Danaher Corporation
• Merck KGaA
• Agilent Technologies, Inc.
• Beckman Coulter, Inc.
• Cytiva
• Miltenyi Biotec
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc.
• Lonza Group AG
• STEMCELL Technologies Inc.
• Eppendorf AG
• QIAGEN N.V.
• Fujifilm Holdings Corporation